Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
123I-EGF internalisation in tu...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
書目詳細資料
Main Authors:
Cornelissen, B
,
Remaut, K
,
Kersemans, V
,
Oltenfreiter, R
,
Burvenich, I
,
Slegers, G
格式:
Conference item
出版:
2004
持有資料
實物特徵
相似書籍
職員瀏覽
實物特徵
總結:
相似書籍
123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
由: Cornelissen, B, et al.
出版: (2004)
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
由: Cornelissen, B, et al.
出版: (2005)
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
由: Cornelissen, B, et al.
出版: (2005)
Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
由: Oltenfreiter, R, et al.
出版: (2004)
A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
由: Cornelissen, B, et al.
出版: (2003)